A stem cell therapy trial aimed at reducing neuroinflammation in patients with presymptomatic Alzheimer’s disease is underway at UTHealth Houston.
US trade commission explores impact of patent rules on COVID diagnostics
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The U.S. International Trade Commission